| Literature DB >> 31590227 |
Frauke Luft1, Sarvi Sharifi2, Winfred Mugge3, Alfred C Schouten3,4, Lo J Bour2, Anne-Fleur van Rootselaar2, Peter H Veltink5, Tijtske Heida5.
Abstract
There is no objective gold standard to detect tremors. This concerns not only the choice of the algorithm and sensors, but methods are often designed to detect tremors in one specific group of patients during the performance of a specific task. Therefore, the aim of this study is twofold. First, an objective quantitative method to detect tremor windows (TWs) in accelerometer and electromyography recordings is introduced. Second, the tremor stability index (TSI) is determined to indicate the advantage of detecting TWs prior to analysis. Ten Parkinson's disease (PD) patients, ten essential tremor (ET) patients, and ten healthy controls (HC) performed a resting, postural and movement task. Data was split into 3-s windows, and the power spectral density was calculated for each window. The relative power around the peak frequency with respect to the power in the tremor band was used to classify the windows as either tremor or non-tremor. The method yielded a specificity of 96.45%, sensitivity of 84.84%, and accuracy of 90.80% of tremor detection. During tremors, significant differences were found between groups in all three parameters. The results suggest that the introduced method could be used to determine under which conditions and to which extent undiagnosed patients exhibit tremors.Entities:
Keywords: Parkinson’s disease; accelerometers; automatic detection; electromyography; essential tremor; movement disorders; tremor; tremor stability index
Mesh:
Year: 2019 PMID: 31590227 PMCID: PMC6806079 DOI: 10.3390/s19194301
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Overview of patients’ details.
| Subject | Gender | Age | Disease Onset | Medication |
|---|---|---|---|---|
| * PD 1 | M | 58 | 50 | Levodopa, Trihexyphenidyl |
| * PD 2 | M | 69 | 64 | Rasagiline, propranolol |
| * PD 3 | M | 67 | 63 | Trihexyphenidyl |
| * PD 4 | F | 81 | 76 | Levodopa-Carbidopa, metoprolol tartrate |
| * PD 5 | F | 62 | 60 | Levodopa |
| Ϯ PD 6 | M | 49 | 47 | Levodopa-Carbidopa, ropinirole hydrochloride |
| Ϯ PD 7 | M | 71 | 71 | - |
| Ϯ PD 8 | F | 43 | 40 | Trihexyphenidyl, ropinirole hydrochloride |
| Ϯ PD 9 | M | 78 | 76 | Levodopa-Carbidopa, Rasagiline, perindopril, omeprazole, pravastatin |
| Ϯ PD 10 | M | 68 | 60 | Levodopa-Carbidopa |
| * ET 1 | M | 45 | Childhood | - |
| * ET 2 | F | 81 | Childhood | - |
| * ET 3 | M | 85 | Childhood | Propranolol |
| * ET 4 | M | 65 | Teenager | - |
| * ET 5 | F | 51 | Childhood | - |
| Ϯ ET 6 | M | 49 | 40 | Propranolol |
| Ϯ ET 7 | M | 54 | Teenager | - |
| Ϯ ET 8 | M | 70 | Childhood | - |
| Ϯ ET 9 | M | 64 | Teenager | - |
| Ϯ ET 10 | M | 55 | Teenager | - |
(*) Training set. (Ϯ) Validation group. M = Male; F = Female.
Figure 1Time signals and corresponding power spectral densities (PSD) of a healthy control (black) and a tremor patient (grey). From top to bottom, data recorded during rest (RT), posture (PT), and movement (MT). On the right side, an enlargement of the PSD of the HC is given.
Tremor classification method—training and validation.
| Threshold (Training Set) | ValGroup 1 | ValGroup 2 | ||||
|---|---|---|---|---|---|---|
| 0.35 | 0.40 | 0.45 | 0.50 | 0.40 | 0.40 | |
| Sensitivity (%) | 92.64 | 84.84 | 76.09 | 66.20 | 78.31 | 92.12 |
| Specificity (%) | 87.13 | 96.45 | 99.10 | 99.70 | 95.00 | 95.00 |
| Accuracy (%) | 89.81 | 90.80 | 87.90 | 83.40 | 90.06 | 94.38 |
| TW HC (%) | 7.22 | 1.20 | 0 | 0 | 6.76 | 1.62 |
Sensitivity, specificity, accuracy and tremor windows (TWs) detected in the Training set (middle column) for all threshold settings. The right column contains the results of the validation groups: accelerometer data of Validation Group 1 (marked with Ϯ in Table 1) and EMG data of all subjects (Validation Group 2). HC = healthy controls; TW = Tremor window; ValGroup 1 = Validation Group 1; ValGroup 2 = Validation Group 2.
Figure 2Group mean tremor stability index (TSI) of the healthy control (HC), essential tremor (ET), and Parkinson’s disease (PD) groups. In each spider plot on the left side are the results of the EMG data (top to bottom: RT, PT, and MT), and on the right side are the results of the accelerometer data. In black, the TW results are displayed, and in grey, the results of the NTW.
Results of the statistical analysis.
| Parameter | Task | p-Value TW | p-Value NTW | ||
|---|---|---|---|---|---|
| EMG | ACC | EMG | ACC | ||
| TSI | RT | - | - | - | - |
| PT | < 0.001 Ϯ | - | < 0.001 * | < 0.001 Ϯ | |
| MT | 0.004 * | - | - | 0.02 * | |
An overview of the results of the statistical analysis of the TSI. Only statistically significant results are given (p < 0.05). The asterisk (*) marks the results where the HC group was significantly different from the ET group. The (Ϯ) denotes the tasks/parameters where the HC group is significantly different from both patient groups.